An underground market for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.
Experimental Drug Acquiring Popularity Online
Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its supposed fat-burning properties. Viewers are encouraged to message these profiles privately for supplier links, while also receiving discount codes.
Active Commerce on Messaging Platforms
Separately, a flourishing trade exists on messaging services, where groups with thousands of members share comparison images, injection guides and claims of rapid UK delivery. Vendors market the drug there before directing buyers to WhatsApp for purchases.
Understanding Retatrutide
Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.
Healthcare Professionals Voice Concerns
Nevertheless, physicians and chemists have cautions that the distribution of what is still an unlicensed medication in the United Kingdom is a cause for concern and could lead to individuals administering products of unknown origin.
Several professionals said the demand for retatrutide could be linked to the increasing price of licensed weight loss treatments such as Mounjaro.
Legal Position and Enforcement
Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Several content creators try to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still breach medicines, advertising, and consumer regulations, risking penalties, legal action or imprisonment.
Service Response and Content Removal
According to the social media company, the service has removed problematic content and prohibited associated keywords and search suggestions. The organization stated it was dedicated to maintaining the service secure and investing in strengthening compliance measures.
Online Marketplace Operations
Investigations also discovered communities with up to nine thousand participants marketing retatrutide using Telegram's integrated discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays groups with thousands of members, populated with images of weight loss, positive testimonials and step-by-step guides for preparing or injecting at residence.
After moments of entering one community, a seller posted contact information, where most transactions occur. The vendor sent an guidebook and promised shipping within 48 hours. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about weight, medical conditions or past usage.
Product Details and Costs
Within these groups, messages display dark colored packages with Royal Mail stickers, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at residence with purified liquid, or pre-filled injectors usually sold at 160 pounds for 20mg. When asked how much time a injector should last, sellers give contradictory answers ranging from a few weeks to “depends on your body”.
Service Moderation and Security Actions
A representative for Telegram said it regularly monitored harmful content on its service including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“Individuals are administering substances they can’t verify. Although the research behind retatrutide is valid, these digital products may not contain what they advertise,” said Jason Murphy, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the surge in interest to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But fake injections are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she explained.
Her team has already seen patients harmed by personal administration from unconfirmed suppliers. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your health,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”
Producer Position
A representative from Eli Lilly said the substance was in third stage research studies and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they said, adding that any product “misleadingly claiming itself as a company experimental product not yet approved … may expose patients to potentially serious medical dangers”.
